World Disease Weekly back issues from November 2004:
Emerging food technology and world health reviewed.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A researcher reviews emerging food technology and world health in a recent issue of the Journal of Food Science. According to a study from the United States, "Both under- and overnutrition are among the major challenges to world health ....
New PAHO fact sheets on HIV reflect differences in cost, care, coverage.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- The Pan American Health Organization (PAHO) issued reports on the first 7 of 47 countries and territories with new and specific data on the care and treatment of people with HIV in the Americas. They reflect a wide range of differences on prices, ...
Ethical principles for collective immunization programs outlined.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers outline ethical principles for collective immunization programs in the journal Vaccine. According to a study from the Netherlands, "Ethical issues arise in discussion of both the content and implementation of collective ...
U.N. hopes guidelines for Mozambican mothers will help reduce child mortality.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Mozambican mothers have been encouraged to familiarize themselves with a book outlining measures to reduce health risks for their children, but the challenges of a life of poverty make it difficult for many to adhere to the most basic guidelines. ...
Children are facing high risk of pesticide poisoning.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Children are facing higher risks from pesticides than adults and need greater protection against these chemicals, particularly in developing countries, according to a joint report published by the U.N. (United Nations) Food and Agriculture ...
HIV-1 superinfections assessed by autologous heteroduplex mobility.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Scientists have assessed HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso by an autologous heteroduplex mobility procedure. In a recently published article, scientists in France and Burkina Faso conducted a ...
Current state of HIV and AIDS in Sub-Saharan Africa reviewed.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers review the current state of AIDS and HIV in Sub-Saharan Africa in a recent issue of the Croatian Medical Journal. According to a study from Malawi and the United States, "Sub-Saharan Africa is the region most severely ...
HIV-1 immunogen vaccine plus antiretrovirals promotes virologic control.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Therapeutic immunization with an inactivated HIV-1 immunogen plus antiretrovirals promotes virologic control in asymptomatic HIV-infected subjects. According to a study from Spain, "To determine whether the addition of an ...
Estrogen protects male rats from aneurysm.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- When it comes to abdominal aortic aneurysms - life-threatening bulges or weak areas in the main artery feeding blood to the lower half of the body - it is definitely better to be female. During 2000, about 11,000 people in the United ...
FDA approves medical device to treat AAA.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms (AAA), a disease that kills more people annually ...
New technique to repair aneurysms safer.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Repairing a life-threatening bulge in a major stomach artery by threading a patch up from the groin appears to sharply cut the short-term risk of death and complications, compared with traditional surgery, Dutch researchers have found. ...
Concentra receives full URAC accreditation in field case management.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Concentra, Inc., has been awarded field case-management accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry. "Concentra should be commended ...
Multiresistant Acinetobacter baumannii outbreak occurred in surgical room.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Multi-resistant Acinetobacter baumannii outbreak occurred in a surgical room in Germany. "Outbreaks of Acinetobacter baumannii demonstrating multiple antibiotic resistance, including meropenem resistance, have been described as severe ...
Phase II study of zileuton for moderate-to-severe acne begins.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company focused on the discovery, development, and commercialization of products for respiratory, inflammatory, and critical care diseases, announced that it will begin enrolling patients in ...
Loss of clone with FLT3 gene mutation at relapse does not improve AML prognosis.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- The loss of a clone with an FLT3 gene mutation at relapse does not improve the prognosis of acute myeloid leukemia. According to recent research from Germany, "Internal tandem duplications (ITDs) of the juxtamembrane region of the FLT3 ...
Genetic profiling links key genes to alcohol-related expectancies.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Genetic profiling links key genes to alcohol-related expectancies. According to recent research from the United States, "molecular genetic research has identified promising markers of alcohol dependence, including alleles of the D-2 ...
U.S. HHS awards grants to treat co-occurring substance abuse/mental disorders.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- U.S. Health and Human Services (HHS) Secretary Tommy G. Thompson announced the award of 4 grants totaling $19.3 million over 5 years to increase the capacity of state treatment systems to provide effective, coordinated and integrated treatment ...
Membrane Cofactor Protein identified as adenovirus receptor.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Membrane Cofactor Protein is identified as the adenovirus receptor. "A tandem mass spectrometry-based approach is demonstrated for detecting a receptor for Ad37, one of the causative agents for epidemic keratoconjunctivitis. Partial ...
Growth hormone treatment stimulates adiponectin gene expression in adipocytes.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. "Growth hormone (GH) is an important regulator of adiposity and systemic energy metabolism. Here, we have investigated the effects of GH ...
Carbohydrate response element-binding protein gene expression studied.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Scientists have studied the modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. "Carbohydrate response element-binding protein (ChREBP) is a rat homolog of human ...
Measurement site affects estimate of subcutaneous and visceral adiposity.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Measurement site affects the estimate of abdominal subcutaneous and visceral adipose tissue. According to recent research from Canada, "We evaluated the influence of measurement site on the ranking (low to high) of abdominal ...
Increased insulin not needed for increases in mouse brain tryptophan.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Increased insulin is not required for beta[subscript]2-adrenoceptor-induced increases in mouse brain tryptophan. "The current study tested the hypothesis that beta[subscript]2-adrenoceptor-mediated increases in brain tryptophan are ...
Combination therapy for liver cancer is linked to interstitial pneumonia.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Combination therapy for liver cancer is linked to interstitial pneumonia. According to recent research published in the Journal of Gastroenterology, "previously we reported combined chemo-immunotherapy using interferon (IFN)-alpha and ...
Genes involved in valproic acid teratogenicity identified.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Genes involved in teratogenicity induced by the antiepileptic drug valproic acid (VPA) have been identified. "Embryonic development is a highly coordinated set of processes that depend on hierarchies of signaling and gene regulatory ...
Slightly increased risk of ischemic stroke found with tamoxifen.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers at Duke University Medical Center have found a slightly elevated risk of ischemic stroke due to a blood clot in the brain in patients treated with tamoxifen, a drug commonly prescribed both for preventing breast cancer and treating ...
Study documents adverse events of pneumococcal vaccine in children.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Examination of reports from the first 2 years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a new study. ...
Study suggests caution against using certain drugs to unclog heart arteries.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Dartmouth Medical School cardiology researchers have discovered a new mechanism for what drives the growth of muscle tissue in the lining of injured heart vessels that can eventually lead to blockage. Their study, reported in the October ...
Candela enters exclusive distribution agreement for China.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Candela Corp. (CLZR), a company focused on the development and commercialization of aesthetic laser systems, and Chindex International, Inc., (CHDX), an independent American provider of western healthcare products and services in the People's ...
New technique targets pesticide-resistant insects.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Australian and U.K. scientists have developed a technique to effectively control the "super pests" that are highly resistant to pesticides used on important food and fiber crops worldwide. The technique, patented by the New South Wales ...
Ethanol effects on uncoupling protein-1 mRNA alter thermogenesis set point.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- The effects of ethanol on uncoupling protein-1 mRNA in brown adipose tissue alter the thermogenesis set point. According to recent research from Japan, "Expression of uncoupling protein-1 (UCP1) is increased by cold acclimation and ...
Study: Anti-dust mite covers effective in reducing allergens.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A new study provides evidence that people who have allergic asthma and use dust mite-impermeable bed covers have improved peak flow measurements. These findings are featured in the October 2004 Journal of Allergy & Clinical Immunology ...
Allergen immunotherapy reviewed.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers review allergen immunotherapy in a recent issue of American Family Physician. According to recent research from the United States, "Allergen immunotherapy (also called allergy vaccine therapy) involves the administration of ...
NFAT1 protein assists mast cells with interleukin-13 gene transcription.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- NFAT1 protein assists mast cells with interleukin-13 gene transcription. "Th2 and mast cells are participants in the asthmatic response to allergens, and both cell types produce the cytokines interleukin (IL)-4 and IL-13. IL-13 in ...
Patient knowledge of allergy immunotherapy better than expected.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Patient knowledge of allergy immunotherapy was better than expected. "Immunotherapy is an invaluable therapy for allergic asthma, allergic rhinitis, and hymenoptera hypersensitivity. It is, however, not without risks. To examine patient ...
Female pattern hair loss affects about 30 million U.S. women.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Each year, women spend countless hours and dollars on their hair. It can play a major role in a woman's self-confidence and self-esteem, making female pattern hair loss a potentially debilitating condition, socially, and emotionally. But it doesn't ...
Biotechcompany scientist presented with award from Alzheimer Association.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Prana Biotechnology Limited (NASDAQ:PRAN)(NASDAQ:ASX:)(NASDAQ:PBT) announced that Dr. Ashley Ian Bush, cofounding scientist and senior scientific consultant to Prana Biotechnology, was named a 2004 Zenith Fellow Award winner by the Alzheimer's ...
Blood pressure drugs may slow deterioration of Alzheimer.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Certain blood pressure drugs may slow the deterioration of Alzheimer disease, according to a new study. Called angiotensin-converting enzyme inhibitors, or ACE inhibitors, the drugs are used to treat high blood pressure. Only ACE ...
Degree of upregulation of some antioxidant defenses differs by sex.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Certain antioxidant defense activities occur at higher levels in females than males, and vice versa, study data show. "Since oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD) and since the ...
Forecast: Considerable research to be devoted to pathomechanism of Alzheimer.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Management of Alzheimer disease remains a challenge, with nearly 8 million sufferers from this condition in the 7 major world markets and anticipated increases in the future. Considerable research is in progress to understand the ...
NSAID prodrugs show promise for CNS delivery.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A series of prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) show promise for CNS delivery of these agents. NSAIDs "have been proposed to prevent or to cure Alzheimer disease," according to scientists in Italy. With ...
Neuronal transport may play a role in neuritic degeneration.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Neuronal transport may play a role in neuritic degeneration. According to a study from the United States, "The presence of amyloid plaques in the brain is one of the pathological hallmarks of Alzheimer disease (AD). We report here a ...
Partnership between government, industry will streamline clinical trials.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- The U.S. National Institute on Aging (NIA) is launching a landmark study to find neuroimaging and other methods for monitoring the progression of Alzheimer disease (AD) aimed at significantly reducing the time and cost of clinical trials. ...
Pharma company announces progress with Alzheimer strategy.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) has made steady progress pursuing a multipronged strategy against Alzheimer disease (AD) that targets the prevention, diagnosis and treatment of AD, according to Dr. Michael Munzar, the company's ...
Pharma company's long-term study of Celebrex expected to continue.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion. The ongoing studies, which are ...
U.S. government to launch major study of Alzheimer patients.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- About 800 older Americans will be asked to lend their brains to science this spring, part of a major government study to track early Alzheimer disease. Researchers will use brain-scanning MRIs and other tests to track people who have ...
p-tau 231 assay improves early stage Alzheimer disease detection.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- An assay developed by Applied NeuroSolutions (APNS), when combined with magnetic resonance imaging (MRI), was shown to identify neural signposts in patients with mild cognitive impairment (MCI), a condition known to increase the risk of developing ...
CytRx adds three drug candidates with acquisition of Biorex assets.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (CYTR) has acquired all the clinical and pharmaceutical assets and related intellectual property of Hungary-based Biorex Research & Development, RT, (Biorex), a privately held biotechnology company focused on the development of novel ...
Horizon Healthcare Services enters agreement with Ancillary Care Management.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Ancillary Care Management (ACM) announced an agreement with Horizon Healthcare Services, Inc., of New Jersey to deploy ACM's Authorization Management System (AMS) and Claims Management System (CMS). The agreement will enable Horizon to ...
Phase I trial of Hematide initiated.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Affymax, Inc., announced that it has initiated a placebo controlled, phase I dose-finding clinical trial with its lead product candidate, Hematide, a peptide-based erythropoiesis stimulating agent (ESA) that has been designed to stimulate ...
Study investigates cardiovascular responses to norepinephrine.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers have investigated regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. Reduced pressor responsiveness to ...
JCAHO Sentinel Event Alert issued targeted at preventing anesthesia awareness.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems (ASPM) announced that the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has issued a new Sentinel Event Alert (issue no. 32) aimed at preventing and managing the impact of anesthesia awareness. ...
Porcine model study found propofol to be more arrhythmogenic than thiopental.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- An electrophysiological study in a porcine model including acute alcoholic intoxication has been conducted to investigate the comparative effects of thiopental and propofol on atrial vulnerability. Atrial tachyarrhythmias (AT) frequently ...
Company introduces low permeability AAA Device.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- W. L. Gore & Associates, Inc., a manufacturer of expanded polytetrafluoroethylene (ePTFE) vascular grafts and endovascular devices including the GORE EXCLUDER Bifurcated Endoprosthesis, announced another product in the endo-AAA EXCLUDER Device ...
Human endothelial cells from different types of vasculature warrant study.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A recent study investigated homocystein levels, hemostatic risk factors, and restenosis after carotid thromboendarterectomy. Researchers in Norway conducted a prospective, observational study "to investigate the effect of elevated serum ...
Microvascular dysfunction encourages the progression of steatohepatitis in mice.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Microvascular dysfunction encourages the progression of steatohepatitis in mice. According to recent research from the United States, "in alcoholic steatohepatitis, hepatic microvascular changes have pathogenic significance for ...
Shear-dependent platelet aggregation unaffected by aspirin.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Shear-dependent platelet aggregation was shown to be unaffected by aspirin. According to a study from the United States, "Mechanisms of shear-induced platelet aggregation are not established. Data that ristocetin-induced von Willebrand ...
System may aid therapies to lower incidence of acute coronary artery diseases.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A recent report described an intravascular probe for detection of vulnerable plaque. Investigators in the United States report, "Coronary angiography defines geometry of lumen of artery. However, perhaps 70% of heart attacks occur when ...
Vitamin E can increase carotid artery compliance and baroreflex gain.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A recent report described the effect of vitamin E on carotid artery elasticity and baroreflex gain in young, healthy adults. According to published research from Hungary, "In [our] study we tested the hypothesis that dietary vitamin E ...
Augmented beta-endorphin is found in patients with coronary artery disease.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Researchers have investigated myocardial and peripheral concentrations of beta-endorphin before and following myocardial ischemia and reperfusion during coronary angioplasty. According to a study from Taiwan, "There is substantial ...
Abnormally small female knockout mice are incompetent mothers.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Female mice that are abnormally small due to gene knockout technology are also bad mothers whose poor parenting skills cause their young to die within a day or two of birth, scientists reported. Since Chawnshang Chang, PhD, cloned the ...
New laboratory provides key research into animal diseases.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- A new $58 million lab at Michigan State University will be a key to detecting diseases that start in animals but can be transmitted to people. The Diagnostic Center for Population and Animal Health officially opened this month. ...
Prescriptions for antibiotics to prevent anthrax now uncommon.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to a new study. Nationwide, more than ...
Researchers begin evaluating efficacy of JuvImmune immunostimulant platform.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Juvaris BioTherapeutics, Inc., announced that researchers at the University of New Mexico have begun evaluating the efficacy of the JuvImmune immunostimulant platform against anthrax and small pox infection models. This novel technology ...
Study of primary care doctors' response to 2001 attacks shows prudent care.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- Primary care physicians working only blocks away from the New York City anthrax attacks of October 2001 acted responsibly and rationally in the midst of the crisis, according to New York-Presbyterian Hospital/Weill Cornell Medical Center ...
Biotech company working to address problem of antibiotic resistance.
Nov 02, 2004 ... 2004 NOV 2 - (NewsRx.com & NewsRx.net) -- New biotechnology company, RiboNovix, Inc., is addressing the worsening problem of antibiotic-resistant bacteria by developing new anti-infectives that are less susceptible to drug resistance. Over the last few months, RiboNovix has ...